Understanding the tumor microenvironment for effective immunotherapy

Cited by (342)

Items 301–342 of 342

1. Additional file 4 of Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response
   Habib Sadeghirad, James H. Monkman, Chin Wee Tan, Liu, Ning, Joseph Yunis, Meg L. Donovan, Afshin Moradi, Niyati Jhaveri, Chris Perry, Mark N. Adams et al. · 2024 · Figshare
2. Construction of immune related prognostic model for pancreatic ductal adenocarcinoma based on single cell RNA-seq analysis
   Kai Chen, Qi Wang, Xinxin Liu, Feng Wang, Yongsu Ma, Shupeng Zhang, Zhijiang Shao, Yang Yinmo, Xiaodong Tian · 2022 · Research Square
3. Additional file 1 of Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response
   Habib Sadeghirad, James H. Monkman, Chin Wee Tan, Liu, Ning, Joseph Yunis, Meg L. Donovan, Afshin Moradi, Niyati Jhaveri, Chris Perry, Mark N. Adams et al. · 2024 · Figshare
4. Additional file 1 of Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pancreatic adenocarcinoma
   Sara R. Savage, Yuefan Wang, Chen, Lijun, Scott D. Jewell, Chelsea J. Newton, Yongchao Dou, Qing Kay Li, Bathe, Oliver F., Robles, Ana I., Gilbert S. Omenn et al. · 2024 · Figshare
5. Additional file 1 of METTL14 regulates CD8+T-cell activation and immune responses to anti‐PD‐1 therapy in lung cancer
   Sun, Chongqi, Wang, Jian, Li, Huixing, Liu, Luyao, Lin, Yu, Zhang, Ling, Xianglong Zu, Yizhi Zhu, Shu, Yongqian, Dong Shen et al. · 2024 · Figshare
6. Additional file 2 of Crosstalk between metabolism and cell death in tumorigenesis
   Shichao Yang, Caden Hu, Chen, Xiaomei, Tang, Yi, Li, Juanjuan, Yang, Hanqing, Yang, Yi, Ying, Binwu, Xiao, Xue, Li, Shang‑Ze et al. · 2024 · Figshare
7. Additional file 2 of Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response
   Habib Sadeghirad, James H. Monkman, Chin Wee Tan, Liu, Ning, Joseph Yunis, Meg L. Donovan, Afshin Moradi, Niyati Jhaveri, Chris Perry, Mark N. Adams et al. · 2024 · Figshare
8. Role of Cancer-Associated Adipocytes in the Progression of Breast Cancer
   Ancuta Jurj, Cristina Alexandra Ciocan, Lajos Raduly, Oana Zănoagă, Ioana Berindan‐Neagoe, Cornelia Braicu · 2025 · Springer eBooks
9. Overcoming Challenges of CAR T-Cell Therapy in Solid Tumor Microenvironments
   Ram Ishwar Garg, Shiv Charan, Deeksha Pal, Umesh Kumar, Ashutosh Rai, Ravinder Singh, Bikash Medhi · 2026 · Springer eBooks
10. LncRNA CDKN2B-AS1 C-Allele: A High-Risk Genetic Determinant in Cancer Susceptibility and Progression Impacting Immune Cell Modulation Dynamics with Therapeutic Implications
    Elisa William Makdessi, Samar Hamoui, Fida El-Ayoubi, Malak Nabulsi, David Wehbe, Noha Ibrahim, Nadine Nasreddine, Nehman Makdissy · 2026 · medRxiv
11. Enhancing Predictive Accuracy in Immunotherapy Models through Data Integration and Parameter Identifiability
    Yixuan Wang, Daniel R. Bergman, Erica Trujillo, Andrea Ziblat, Anthony A. Fernald, Lie Li, Alexander T. Pearson, Randy F. Sweis, Trachette Levon Jackson · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
12. Stochastic process tumor growth and metastasis cancer progression and survival analysis
    S. Vetrivel, S. Sasikala · 2026 · Network Modeling Analysis in Health Informatics and Bioinformatics
13. Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers
    Ghaleb Oriquat, Waleed K. Abdulsahib, Sajida Hussein Ismail, R Roopashree, Pradeepta Sekhar Patro, Jayshree Nellore, Gunjan Mukherjee, Ashish Singh Chauhan, Saodat Musaeva · 2026 · Annals of Hematology
14. Local and systemic immune profiles in tumors
    Svetlana Aleksandrovna Kulyova, O. E. Savelieva, Ирина Александровна Балдуева, Ksenia M. Borokshinova, Е. А. Михайлова, Т. Л. Нехаева, Alika A. Kulyova, Evgeny M. Senchurov · 2026 · Advances in molecular oncology
15. KLS-3021: Innovative oncolytic virotherapy for the treatment of advanced primary and metastatic cutaneous squamous cell carcinoma
    Kiwon Park, Jinwon Seo, Sungmin Lee, Hyesoo Kang, Joonsung Kim, Eunjin Lee, Jaeil Shin, Soon-Oh Hong, Sujeong Kim, Sun Jin Kim · 2026 · Molecular Therapy Oncology
16. Comprehensive pan-cancer analysis of FSCN1 as a marker for prognosis and immunity
    Rui Xu, Wanxin Xu, Changqing Dong, Guangliang Qiang · 2026 · Discover Oncology
17. TIM-3 in Cardiovascular Disease
    Laura I.E. Yousif, Aukje G. Sijtema, Margot J. Chevalier, Rudolf A. de Boer, Wouter C. Meijers · 2026 · Current Heart Failure Reports
18. Immune Checkpoint Expression in Cancer: Mechanisms and Implications for Immunotherapy
    Lobat Tayebi, Mohsen Abdolmaleki · 2026 · Springer eBooks
19. Myositis-Myasthenia Overlap Syndrome After Immune Checkpoint Inhibitor Treatment: A Case Report
    Christopher S. Awad, Jack C Redick, Sydney Scheel, Neal Pohlman, Sorabh Khandelwal, Jason J. Bischof · 2026 · Cureus
20. Role of monoclonal antibody, immune checkpoint inhibitors, and programmed death ligand 1 in cancer immunotherapy
    Ashna Gupta, Gunjan Dagar, Mohd Umar Rehmani, Suraja Kumar Das, Muzafar Ahmad Macha, Mukesh Tanwar, Ajaz Ahmad Bhat, M Singh · 2026 · Elsevier eBooks
21. Immunotherapy and Breast Reconstruction: Opportunities, Challenges, and Future Directions
    Shuang Li, Jianguo Wang, Yingjie Liu, Wenwu Cai, Weichang Zhang, Shengyun Li, Yunjian Zhang · 2026 · Cancer Medicine
22. Acidosis Drives Vasculogenic Mimicry in PDAC CSCs via Na+/H+ Exchanger Isoform 1 (NHE1) and Calcium Entry
    Maria Raffaella Greco, Francesca Fracasso, Stefania Cannone, Daria Di Molfetta, Marilena Ardone, Sharon Natasha Cox, Brunella Rita Ladogana, Daniela Isabel Abbrescia, Apollonia Tullo, Marianna Ranieri et al. · 2026 · Cells
23. Breast cancer stem cells mediated CD8 + T cell exhaustion among different molecular subtypes of breast cancer regulated via NOTCH1/RBPJ/PD-L1 axis
    Jasmine Sultana, Aishwarya Guha, Mohona Chakravarti, Goutam Ulgekar, Saurav Bera, Pritha Roy Choudhury, Sukanya Dhar, Juhina Das, Nilanjan Ganguly, Anirban Sarkar et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
24. A Pan-Cancer Multi-Omics Analysis of CAD: Integrating CRISPR and Metabolomics Data to Unravel the Metabolic–Immune Axis and Immunotherapy Response
    Yi-Yan Li, Ao-Xue Xing, Wenzhen Li, Yiman Zhang, Kejuan Zhang, Tian-Hao Xie, Gang Wu, Wei Zhang · 2026 · Biomedicines
25. Pan-cancer screening, bioinformatics analysis, and experimental validation identify TEX10 as a key biomarker driving OSCC progression
    Ruonan Sun, Jiahong Zhao, Jie Guo, Linyu Jin, Jilun Liu, Hui Xu, Yunfang Bai · 2026 · Frontiers in Genetics
26. Akdeniz Üniversitesi Tıp Fakültesi Hastanesi’nde Nivolumab Tedavisi Uygulanmış Olan Hastalarda Akut Böbrek Hasarının Retrospektif Olarak Değerlendirilmesi
    Üçler Can Ateş, Funda Sarı · 2026 · Akdeniz Medical Journal
27. SPP1-positive myeloid cell subpopulations associated with resistance to PD-1/L1 immunotherapy in lung adenocarcinoma
    R Q Zhang, Cancan Wang, Xiaomei Ma, Xiangpeng LI · 2026 · Scientific Reports
28. Targeting the tumor microenvironment in glioblastoma: Mechanistic insights, therapeutic strategies, and advances in immunotherapy
    Mudassir Khattak, Ismail Jadoon, Muhammad Umair, Ariba Waqar, Aftab Ullah, Amna Nisar, Junaid Ahmad · 2026 · Life Sciences
29. Deep learning of CT imaging predicts PD-L1 expression and immunotherapy response in metastatic NSCLC: A multi-center study
    A. Muneer, E. Showkatian, Maliazurina B. Saad, L. Hong, Shen-Duo Li, Morteza Salehjahromi, M. Aminu, S. Sujit, Hui Xu, M. Waqas et al. · 2026 · Cancer Letters
30. Dual-time-point [18F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy
    S. Thunold, E. Hernes, L. T. Gyland Mikalsen, S. Farooqi, Å. Öjlert, R. J. Francis, A. K. Nowak, W. Szejniuk, S. S. Nielsen, S. Cedres et al. · 2026 · EJNMMI Research
31. Integrated pan-cancer profiling highlights OSR2 as a prognostic indicator and immune-associated biomarker
    Lei Tang, Qiqi Chen, Chunmiao Han, Yuanyuan Wang, Jianbo Li, Yunsong Liu · 2026 · Discover Oncology
32. Robust Isolation and Multiplexed Identification of Circulating Rare Cells via Continuous Centrifugal Microfluidics and Hydrogel Immunocytochemistry
    Hyeong Jung Woo, Hyun Gyu Kang, Sohae Yang, Hyejin Song, Seoyoung Lee, Sun Min Lee, Jungmin Lee, Sun-Young Kong, Jae Young Joung, Hye Ryun Kim et al. · 2026 · Journal of Visualized Experiments
33. Patient stratification in exercise oncology: matching exercise modalities to immune phenotypes to optimize immunotherapy response
    Li Zeng, Xiaotong Du, Zhenyu Yang, Yang Wu, Moxun Tang, Fengyan Liang, Linhua Chen, Xinming Ye · 2026 · Translational Oncology
34. Tumor Immune Regulation by Natural Products: Mechanistic Insights and Therapeutic Potential
    Qianqian Wang, Z D Zhang, Xiaotong Sun, Z D Zhang, Qiwen Lu, Shan Deng, Xuan Han · 2026 · The American Journal of Chinese Medicine
35. Emerging roles of circular RNA in cancer immunotherapy: From molecular mechanisms to therapeutic strategies
    Fangmi Yao, Xiaoqing Liang, Guichuan Lai, Ke Wu, Hongzhong Li · 2026 · Genes & Diseases
36. Protocol for high-throughput droplet-engineered TIL-retaining tumor organoids in triple-negative breast cancer
    Xiaolong Zhou, Zhu Y, Wanlong Wang, Yongde Cai, Zhiyuan Liu, Yingshi Su, Shaohua Ma · 2026 · STAR Protocols
37. The Transformation of the Microenvironment: From Observer to Coordinator in Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma Development
    Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Abeer Jabra Shnoudeh, Ilkhom Yuldashev, Dildora Jalilova, Alimova Zebiniso Farxodjon qizi, Rajashree Panigrahi, Rswl Mahmoud Hashem, Neeraj Bainsal · 2026 · Hematological Oncology
38. Development of a mobile high-intensity focused ultrasound platform for preclinical tumor microenvironment modulation in a pancreatic ductal adenocarcinoma mouse model
    Hye Won Shon, Seok-Ki Kim, Gyeongmin Kang, Mi Rim Lee, Yu‐Sun Lee, Sumin Kang, Sun Il Choi, Jiyoung Lee, Daehong Kim, Yun-Hee Kim · 2026 · International Journal of Hyperthermia
39. Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy
    Sourio Chakraborty, Sumon Mukherjee, Subhajit Ghosh, Udit Basak, Sumoyee Mukherjee, Arghya Adhikary, Gaurisankar Sa, Tanya Das · 2026 · APOPTOSIS
40. Therapeutic mRNA vaccines for lung cancer: reshaping the tumor microenvironment to enhance anti-tumor immunity
    Hao Wu, Ruiqi Weng, Siyi Gu, Jiyuan Wang, Xiaoyan Ma, Jiaxuan Li, Xiaotian Tie, Chongmin Huang, Keda Chen · 2026 · Frontiers in Immunology
41. Nanozymes in Tumor Microenvironment Modulation for Cancer Therapy
    Xinyang Zhang, Ziqi Wang, Yangguang Niu, Jingjing Tong, Ranfeng Wang, Yulin Zhu, Pei Pei, Jie Li, Yunan Gao, Xiaoran Deng et al. · 2026 · Biomaterials Research
42. PET imaging enables direct evaluation of ferroptosis in HCC synergistically induced by anti-PD-L1 and Olaparib
    Feng Xiong, Cheng Xu, Pei Wang, Li Ni, Yilin Yang, Buchuan Zhang, Kijung Kwak, Shuang Song, Pengtao You, Xiaohua Zhu et al. · 2026 · Experimental & Molecular Medicine